Filter
19
Filtered Results: 19
Text search:
Medicines
and
Healthcare
products
Regulatory
Agency
(MHRA)
UK
Featured
Recommendations
2
New Publications
6
Language
Document type
No document type
8
Studies & Reports
4
Guidelines
4
Manuals
2
Fact sheets
1
Countries / Regions
Nigeria
1
United Kingdom
1
Brazil
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
2
COVID-19
1
x MEDBOX Issue Brief & Annual Reports x
1
Pediatrics
1
Vaccine-preventable Diseases
1
Cardiovascular Diseases
1
Toolboxes
Epilepsy
2
Vaxzevria (Astra Zeneca)
2
HIV testing & services
1
Background PTSD in children
1
Clinical Aspects, Treatment & Prevention
1
Influenza Prevention & Control
1
Opportunistic Infections
1
Studies
1
General
1
Vaccination & Strategy
1
Videos
1
Access & Strategy
1
Vaccine Candidates & Research
1
Communication Material
1
Immunization Guidelines
1
Dashboards & Resource Platforms
1
mRna Vaccines general
1
Vector-based Vacines General
1
Research & Pipeline
1
Falsified & Substandard
1
Model Formulary
1
Pharmacy Practice
1
Quality Assurance
1
Epilepsy
1
Reports & Studies
1
Neurological Disorders
1
Alzheimer's Disease & Dementia
1
Bipolar Affective Disorders
1
Antiretroviral Treatment ART
1
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
Clinical Guideline
It is recommended that egg based quadrivalent vaccines for use in the 2019-2020 northern hemisphere influenza season contain the following:
an A/Brisbane/02/2018 (H1N1)pdm09-like virus;
an A(H3N2) virus to be announced on 21 March 2019*;
a B/Colorado/06/2017-like virus (B/Victoria/...
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
Posttraumatic stress disorder (PTSD) in children and adolescents occurs as a result of a child’s exposure to one or more traumatic events: actual or threatened death, serious injury, or sexual violence. The victim may experience the event, witness it, learn about it from close family members or fr...
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I...
Epilepsies: diagnosis and management
recommended
Clinical guideline | Published: 11 January 2012 | nice.org.uk/guidance/cg137
Médecins sans Frontières access campaign
Issue Brief
Accessed: 28.11.2019
October 2018
HIV testing services
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
COVID-19 & Vaccination
recommended
Issue Brief no.8. January 18,2021
Vaccination against the spread of the SARS-CoV-2 virus represents a milestone in the fight against the pandemic. Good communication and education of the population is essential for the success of the vaccination. Below is some information on vaccination strategies,...
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim...
Este documento de referência foi preparado pelo Grupo de Trabalho sobre Vacinas contra COVID-19 do Grupo Consultivo Estratégico de Especialistas em Imunização (SAGE) para orientar as discussões do SAGE em sua reunião extraordinária de 8 de fevereiro de 2021, que resultou na publicação do do...
This guidance should be followed if an unlicensed medicine is prepared in
a registered pharmacy. The preparation of an unlicensed medicine (for
example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous preparation’.
The guidance should be read alon...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
